Fact CheckerSign in

NCT06061185Recruiting

Multimodal Computed Tomography in Patients With Acute Hemorrhagic Stroke

Multimodal Computed Tomography in Patients With Acute Hemorrhagic Stroke (MCTAHS)

Source: ClinicalTrials.gov · Last updated 4 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Acute hemorrhagic stroke is a series of neurosurgical diseases characterized by bleeding with high morbidity and mortality. It accounts for about 20% of all strokes worldwide and mainly includes subtypes such as intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH). Multimodal computed tomography including non-contrast computed tomography, computed tomography angiography and computed tomography perfusion, is of great important in understanding pathophysiological changes, evaluating prognosis and guiding interventions in these diseases.

Status (registry)
Recruiting
Study type
Observational
Enrollment
10000 (estimated)
First submitted
10 Sept 2023
Start date
1 Jan 2020
Primary completion date
1 Mar 2032
Lead sponsor
Xiaolin Chen, MD
Diseases
Stroke
NCT number
NCT06061185

What you commit to

  • Study type: Observational
  • Planned participants: 10000
  • From 1 Jan 2020 to the primary completion date, 1 Mar 2032
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • with a history of previous history of ischemic/hemorrhagic stroke;
  • prior treatment such as external ventricular drainage, digital subtraction angiography and lumbar puncture in other institution;

Other illness

  • physical disability due to previous diseases;

Other

  • admission to the emergency department more than a week after symptom onset;
  • serious medical history or existing comorbidities;
  • poor original image quality;
  • incomplete follow-up.

Who the study is looking for

  • age ≥ 18, ≤ 85 years;
  • presence with hemorrhagic stroke

Age in the registry: 18 years to 85 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Beijing Tiantan Hospital
Coordinator of this site? Confirm its status
BeijingChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.